Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Innocan Pharma Corp (OP: INNPF ) 0.1568 UNCHANGED Last Price Updated: 9:30 AM EST, Dec 9, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open 0.1568 Bid (Size) N/A (0) Ask (Size) N/A (0) Prev. Close 0.1568 Today's Range 0.1568 - 0.1568 52wk Range 0.0908 - 0.2431 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Cannabinoid Leader Innocan Pharma's Q3: 174% YoY Revenue Growth November 21, 2024 Innocan Pharma reports 174% YoY revenue growth in Q3 2024, driven by innovation in cannabinoids and strong sales from BI Sky Global Ltd. Via Benzinga CBD-Focused Innocan Pharma Achieves 4X Revenue Growth In Q1, Hits $6.8M Mark May 28, 2024 Innocan Pharma's Q1 2024 revenue surged 334% to $6.8M, driven by strong sales growth from BI Sky Global. Read about financial performance. Via Benzinga Performance YTD -35.50% -35.50% 1 Month +0.06% +0.06% 3 Month -2.06% -2.06% 6 Month -13.85% -13.85% 1 Year -35.50% -35.50% More News Read More This Pharma Co. Kicks Off FDA Approval Process For CBD-Based Treatment Of Chronic Pain April 23, 2024 Via Benzinga Exposures Product Safety 534% Revenue Surge Unveiled By Israeli CBD-Focused Pharma Company, Exceeding Expectations April 02, 2024 Via Benzinga CBD-Focused Pharma Co. Innocan Reveals 433% YoY Increase In 2023 Revenue As It Pursues FDA Approval February 13, 2024 Via Benzinga Exposures Product Safety 4 CBD Stocks in the Canadian Capital Market November 02, 2021 Via Benzinga Key Leadership Changes In Cannabis You Should Know About As We Head Into 2024 December 22, 2023 Via Benzinga Topics Cannabis Exposures Cannabis More Cannabis Funding For FDA And Product Expansion: How This Pharma Tech Company Is Doing It October 23, 2023 Via Benzinga Topics Cannabis Exposures Cannabis Product Safety CBD-Focused Pharma Co. Seeks Funding To Revolutionize Healthcare September 21, 2023 Via Benzinga Innocan Pharma's Q2 2023 Reports Gross Profit Growth Driven By Robust Subsidiary Sales August 28, 2023 Via Benzinga Cannabis Stock Gainers And Losers From August 25, 2023 August 25, 2023 Via Benzinga Topics Cannabis Exposures Cannabis Innocan Pharma Secures $1.4M Via Private Placement August 04, 2023 Via Benzinga Bearish Sentiment Across The Cannabis Space - Check Full Movers For August 21, 2023 August 21, 2023 Via Benzinga Topics Cannabis Exposures Cannabis Innocan Pharma To Secure Up To $3M Via Private Placement Of Units At A 9% Prime Above Share Price July 25, 2023 Via Benzinga Bullish Thursday For Marijuana Stocks - EVIO, Tetra Bio Pharma Among Top Gainers August 17, 2023 Via Benzinga Topics Cannabis Exposures Cannabis Cannabis Stock Movers For July 21, 2023 July 21, 2023 Via Benzinga Cannabis Stock Gainers And Losers From August 14, 2023 August 14, 2023 Via Benzinga Topics Cannabis Exposures Cannabis Innocan Pharma Q1 Revenue Grows 500%, Here Is What You Need To Know June 01, 2023 Via Benzinga Cannabis Stock Gainers And Losers From August 11, 2023 August 11, 2023 Via Benzinga Topics Cannabis Exposures Cannabis Innocan Pharma FY22 Revenue Grows 1205% To $2.6M, Here Is What You Need To Know April 19, 2023 Via Benzinga Can Liposomal CBD Injection Help Dogs With Polyarthritis? Innocan Pharma Reports Clinical Success February 21, 2023 Via Benzinga Innocan Pharma Q3 Revenue Grows 700% YoY, Here Is What You Need To Know November 29, 2022 Via Benzinga Innocan Pharma Provides an Operational Update September 21, 2022 Via Newsfile Topics Intellectual Property Exposures Intellectual Property Innocan Pharma Reports Another Successful Result from a Pre-Clinical Study on a Dog Suffering from Refractory (Drug-Resistant) Epilepsy Following LPT Treatment September 09, 2022 Via Newsfile Innocan Pharma to Participate in the H.C. Wainwright 24th Annual Global Investment Conference on September 12-14, 2022 September 06, 2022 Via Newsfile Stock Quote API & Stock News API supplied by www.cloudquote.io Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
